Last 12 months
Inside the activity.
5 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2021 Filed Nov 23, 2021 16:16 UTC |
Hance Robert BDirector
|
GrantClass A Common Stock | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045777 · doc4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,123 F1 · shares: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:16 UTC |
Hopfield JessicaDirector
|
GrantClass A Common Stock | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045774 · doc4.xml · nonDerivative · entry 1 Hopfield Jessica · CIK 0001648715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,123 F1 · shares: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:16 UTC |
PRAHALAD MURALIDirector
|
GrantClass A Common Stock | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045775 · doc4.xml · nonDerivative · entry 1 PRAHALAD MURALI · CIK 0001829991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,123 F1 · shares: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:16 UTC |
GRAY SUSANNAHDirector
|
GrantClass A Common Stock | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045773 · doc4.xml · nonDerivative · entry 1 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,123 F1 · shares: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:15 UTC |
DAVERMAN BENJAMIN JAMESDirector
|
GrantClass A Common Stock | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045772 · doc4.xml · nonDerivative · entry 1 DAVERMAN BENJAMIN JAMES · CIK 0001829768 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,271 F1 · shares: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:15 UTC |
MARKER LUKE JOSEPHDirector
|
GrantClass A Common Stock | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045768 · doc4.xml · nonDerivative · entry 1 MARKER LUKE JOSEPH · CIK 0001829810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,271 F1 · shares: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:15 UTC |
CUNNINGHAM SEAN LAURENCEDirector
|
GrantClass A Common Stock | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045767 · doc4.xml · nonDerivative · entry 1 CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,271 F1 · shares: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. Read SEC document |
| October 31, 2021 Filed Jan 27, 2022 21:00 UTC |
Dolan ChristineSee Remarks
|
GrantClass A Common Stock | 203 | $22.95 | $4,658.85 |
DisclosureSEC source: 0000899243-22-003414 · doc4.xml · nonDerivative · entry 2 Dolan Christine · CIK 0001684273 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119 F1 · timeliness: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,119 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c). Read SEC document |
| October 31, 2021 Filed Jan 27, 2022 16:00 UTC |
Herde KevinChief Financial Officer
|
GrantClass A Common Stock | 392 | $22.95 | $8,996.40 |
DisclosureSEC source: 0000899243-22-003418 · doc4.xml · nonDerivative · entry 2 Herde Kevin · CIK 0001671595 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 889 F1 · timeliness: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 889 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c). Read SEC document |
| October 31, 2021 Filed Jan 27, 2022 21:00 UTC |
NEEL BRIANSee Remarks
|
GrantClass A Common Stock | 598 | $22.95 | $13,724.10 |
DisclosureSEC source: 0000899243-22-003417 · doc4.xml · nonDerivative · entry 2 NEEL BRIAN · CIK 0001829754 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 884 F1 · timeliness: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 884 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c). Read SEC document |
| October 31, 2021 Filed Jan 27, 2022 21:00 UTC |
ORESHACK KURTGeneral Counsel
|
GrantClass A Common Stock | 542 | $22.95 | $12,438.90 |
DisclosureSEC source: 0000899243-22-003416 · doc4.xml · nonDerivative · entry 2 ORESHACK KURT · CIK 0001832579 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,537 F1 · timeliness: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,037 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c). Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 16:21 UTC |
GTCR INVESTMENT XI LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS 2, LLCDirector · 10% owner
GTCR FUND XI/B LPDirector · 10% owner
GTCR FUND XI/C LPDirector · 10% owner
GTCR CO-INVEST XI LPDirector · 10% owner
GTCR PARTNERS XI/A&C LPDirector · 10% owner
GTCR PARTNERS XI/B LPDirector · 10% owner
|
Disposition to issuerCommon Units · Derivative | 17,068,559 | $50.00 | $853,427,950.00 |
DisclosureSEC source: 0000899243-21-035674 · doc4.xml · derivative · entry 3 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 126,239,611 Underlying: Class A Common Stock · 17,068,559 shares Expires not disclosed F6 · derivative.exercise_price: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F1 · kind: On September 9, 2021, the Reporting Persons sold an aggregate 20,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-259366). The aggregate 20,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 17,068,559 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,931,441 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). F6 · derivative.exercise_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F6 · derivative.expiration_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F7 · ownership.nature: Reflects Common Units owned directly by MLSH 1. Each Common Unit is exchangeable for one share of Class A Common Stock pursuant to the Exchange Agreement. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 16:21 UTC |
GTCR INVESTMENT XI LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS 2, LLCDirector · 10% owner
GTCR FUND XI/B LPDirector · 10% owner
GTCR FUND XI/C LPDirector · 10% owner
GTCR CO-INVEST XI LPDirector · 10% owner
GTCR PARTNERS XI/A&C LPDirector · 10% owner
GTCR PARTNERS XI/B LPDirector · 10% owner
|
OtherClass B Common Stock | 17,068,559 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-035674 · doc4.xml · nonDerivative · entry 2 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 126,239,611 F4 · kind: Reflects the shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") exchanged for shares of Class A Common Stock sold. F4 · shares: Reflects the shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") exchanged for shares of Class A Common Stock sold. F4 · price: Reflects the shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") exchanged for shares of Class A Common Stock sold. F5 · balance_after: Reflects Class B Common Stock held directly by MLSH 1. MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects Class B Common Stock held directly by MLSH 1. MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of his pecuniary interest therein. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 16:21 UTC |
GTCR INVESTMENT XI LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS 2, LLCDirector · 10% owner
GTCR FUND XI/B LPDirector · 10% owner
GTCR FUND XI/C LPDirector · 10% owner
GTCR CO-INVEST XI LPDirector · 10% owner
GTCR PARTNERS XI/A&C LPDirector · 10% owner
GTCR PARTNERS XI/B LPDirector · 10% owner
|
Disposition to issuerClass A Common Stock | 2,931,441 | $50.00 | $146,572,050.00 |
DisclosureSEC source: 0000899243-21-035674 · doc4.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 21,681,033 F1 · kind: On September 9, 2021, the Reporting Persons sold an aggregate 20,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-259366). The aggregate 20,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 17,068,559 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,931,441 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). F1 · shares: On September 9, 2021, the Reporting Persons sold an aggregate 20,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-259366). The aggregate 20,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 17,068,559 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,931,441 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). F2 · balance_after: Reflects Class A Common Stock held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. F3 · balance_after: (Continued From Footnote 2) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. F2 · ownership.nature: Reflects Class A Common Stock held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. F3 · ownership.nature: (Continued From Footnote 2) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. Read SEC document |
| April 30, 2021 Filed Jan 27, 2022 21:00 UTC |
Dolan ChristineSee Remarks
|
GrantClass A Common Stock | 916 | $22.95 | $21,022.20 |
DisclosureSEC source: 0000899243-22-003414 · doc4.xml · nonDerivative · entry 1 Dolan Christine · CIK 0001684273 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 916 F1 · timeliness: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,119 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c). Read SEC document |
| April 30, 2021 Filed Jan 27, 2022 16:00 UTC |
Herde KevinChief Financial Officer
|
GrantClass A Common Stock | 497 | $22.95 | $11,406.15 |
DisclosureSEC source: 0000899243-22-003418 · doc4.xml · nonDerivative · entry 1 Herde Kevin · CIK 0001671595 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497 F1 · timeliness: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 889 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c). Read SEC document |
| April 30, 2021 Filed Jan 27, 2022 21:00 UTC |
NEEL BRIANSee Remarks
|
GrantClass A Common Stock | 286 | $22.95 | $6,563.70 |
DisclosureSEC source: 0000899243-22-003417 · doc4.xml · nonDerivative · entry 1 NEEL BRIAN · CIK 0001829754 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286 F1 · timeliness: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 884 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c). Read SEC document |
| April 30, 2021 Filed Jan 27, 2022 21:00 UTC |
ORESHACK KURTGeneral Counsel
|
GrantClass A Common Stock | 495 | $22.95 | $11,360.25 |
DisclosureSEC source: 0000899243-22-003416 · doc4.xml · nonDerivative · entry 1 ORESHACK KURT · CIK 0001832579 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,995 F1 · timeliness: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,037 shares of Class A Common Stock was also exempt pursuant to Rule 16b-3(c). Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 17:00 UTC |
GTCR INVESTMENT XI LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS 2, LLCDirector · 10% owner
GTCR FUND XI/B LPDirector · 10% owner
GTCR FUND XI/C LPDirector · 10% owner
GTCR CO-INVEST XI LPDirector · 10% owner
GTCR PARTNERS XI/A&C LPDirector · 10% owner
GTCR PARTNERS XI/B LPDirector · 10% owner
|
Disposition to issuerCommon Units · Derivative | 2,304,256 | $31.25 | $72,008,000.00 |
DisclosureSEC source: 0000899243-21-015484 · doc4.xml · derivative · entry 6 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 143,308,170 Underlying: Class A Common Stock · 2,304,256 shares Expires not disclosed F7 · derivative.exercise_price: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F1 · kind: On April 7, 2021, the Reporting Persons sold an aggregate 18,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-255043). The aggregate 18,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 15,361,703 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,638,297 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). On April 8, 2021, the Reporting Persons sold an aggregate of 2,700,000 shares of Class A Common Stock of the Issuer pursuant to the option granted to the underwriters, which was exercised in full prior to closing. F2 · kind: (Continued from footnote 1) The aggregate 2,700,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 2,304,256 shares of Class A Common Stock sold by MLSH 1 and (b) 395,744 shares of Class A Common Stock sold by MLSH 2. F7 · derivative.exercise_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F7 · derivative.expiration_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F8 · ownership.nature: Reflects Common Units owned directly by MLSH 1. Each Common Unit is exchangeable for one share of Class A Common Stock pursuant to the Exchange Agreement. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 17:00 UTC |
GTCR INVESTMENT XI LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS 2, LLCDirector · 10% owner
GTCR FUND XI/B LPDirector · 10% owner
GTCR FUND XI/C LPDirector · 10% owner
GTCR CO-INVEST XI LPDirector · 10% owner
GTCR PARTNERS XI/A&C LPDirector · 10% owner
GTCR PARTNERS XI/B LPDirector · 10% owner
|
OtherClass B Common Stock | 2,304,256 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-015484 · doc4.xml · nonDerivative · entry 4 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 143,308,170 F5 · kind: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F5 · shares: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F5 · price: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F6 · balance_after: Reflects Class B Common Stock held directly by MLSH 1. MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of his pecuniary interest therein. F6 · ownership.nature: Reflects Class B Common Stock held directly by MLSH 1. MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of his pecuniary interest therein. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 17:00 UTC |
GTCR INVESTMENT XI LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS 2, LLCDirector · 10% owner
GTCR FUND XI/B LPDirector · 10% owner
GTCR FUND XI/C LPDirector · 10% owner
GTCR CO-INVEST XI LPDirector · 10% owner
GTCR PARTNERS XI/A&C LPDirector · 10% owner
GTCR PARTNERS XI/B LPDirector · 10% owner
|
Disposition to issuerClass A Common Stock | 395,744 | $31.25 | $12,367,000.00 |
DisclosureSEC source: 0000899243-21-015484 · doc4.xml · nonDerivative · entry 3 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 24,612,474 F1 · kind: On April 7, 2021, the Reporting Persons sold an aggregate 18,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-255043). The aggregate 18,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 15,361,703 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,638,297 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). On April 8, 2021, the Reporting Persons sold an aggregate of 2,700,000 shares of Class A Common Stock of the Issuer pursuant to the option granted to the underwriters, which was exercised in full prior to closing. F2 · kind: (Continued from footnote 1) The aggregate 2,700,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 2,304,256 shares of Class A Common Stock sold by MLSH 1 and (b) 395,744 shares of Class A Common Stock sold by MLSH 2. F1 · shares: On April 7, 2021, the Reporting Persons sold an aggregate 18,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-255043). The aggregate 18,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 15,361,703 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,638,297 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). On April 8, 2021, the Reporting Persons sold an aggregate of 2,700,000 shares of Class A Common Stock of the Issuer pursuant to the option granted to the underwriters, which was exercised in full prior to closing. F2 · shares: (Continued from footnote 1) The aggregate 2,700,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 2,304,256 shares of Class A Common Stock sold by MLSH 1 and (b) 395,744 shares of Class A Common Stock sold by MLSH 2. F3 · balance_after: Reflects Class A Common Stock held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. F4 · balance_after: (Continued From Footnote 3) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects Class A Common Stock held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. F4 · ownership.nature: (Continued From Footnote 3) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 17:00 UTC |
GTCR INVESTMENT XI LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS 2, LLCDirector · 10% owner
GTCR FUND XI/B LPDirector · 10% owner
GTCR FUND XI/C LPDirector · 10% owner
GTCR CO-INVEST XI LPDirector · 10% owner
GTCR PARTNERS XI/A&C LPDirector · 10% owner
GTCR PARTNERS XI/B LPDirector · 10% owner
|
Disposition to issuerCommon Units · Derivative | 15,361,703 | $31.25 | $480,053,218.75 |
DisclosureSEC source: 0000899243-21-015484 · doc4.xml · derivative · entry 5 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 145,612,426 Underlying: Class A Common Stock · 15,361,703 shares Expires not disclosed F7 · derivative.exercise_price: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F1 · kind: On April 7, 2021, the Reporting Persons sold an aggregate 18,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-255043). The aggregate 18,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 15,361,703 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,638,297 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). On April 8, 2021, the Reporting Persons sold an aggregate of 2,700,000 shares of Class A Common Stock of the Issuer pursuant to the option granted to the underwriters, which was exercised in full prior to closing. F2 · kind: (Continued from footnote 1) The aggregate 2,700,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 2,304,256 shares of Class A Common Stock sold by MLSH 1 and (b) 395,744 shares of Class A Common Stock sold by MLSH 2. F7 · derivative.exercise_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F7 · derivative.expiration_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F8 · ownership.nature: Reflects Common Units owned directly by MLSH 1. Each Common Unit is exchangeable for one share of Class A Common Stock pursuant to the Exchange Agreement. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 17:00 UTC |
GTCR INVESTMENT XI LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS 2, LLCDirector · 10% owner
GTCR FUND XI/B LPDirector · 10% owner
GTCR FUND XI/C LPDirector · 10% owner
GTCR CO-INVEST XI LPDirector · 10% owner
GTCR PARTNERS XI/A&C LPDirector · 10% owner
GTCR PARTNERS XI/B LPDirector · 10% owner
|
OtherClass B Common Stock | 15,361,703 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-015484 · doc4.xml · nonDerivative · entry 2 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 145,612,426 F5 · kind: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F5 · shares: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F5 · price: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F6 · balance_after: Reflects Class B Common Stock held directly by MLSH 1. MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of his pecuniary interest therein. F6 · ownership.nature: Reflects Class B Common Stock held directly by MLSH 1. MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of his pecuniary interest therein. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 17:00 UTC |
GTCR INVESTMENT XI LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS 2, LLCDirector · 10% owner
GTCR FUND XI/B LPDirector · 10% owner
GTCR FUND XI/C LPDirector · 10% owner
GTCR CO-INVEST XI LPDirector · 10% owner
GTCR PARTNERS XI/A&C LPDirector · 10% owner
GTCR PARTNERS XI/B LPDirector · 10% owner
|
Disposition to issuerClass A Common Stock | 2,638,297 | $31.25 | $82,446,781.25 |
DisclosureSEC source: 0000899243-21-015484 · doc4.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 25,008,218 F1 · kind: On April 7, 2021, the Reporting Persons sold an aggregate 18,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-255043). The aggregate 18,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 15,361,703 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,638,297 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). On April 8, 2021, the Reporting Persons sold an aggregate of 2,700,000 shares of Class A Common Stock of the Issuer pursuant to the option granted to the underwriters, which was exercised in full prior to closing. F2 · kind: (Continued from footnote 1) The aggregate 2,700,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 2,304,256 shares of Class A Common Stock sold by MLSH 1 and (b) 395,744 shares of Class A Common Stock sold by MLSH 2. F1 · shares: On April 7, 2021, the Reporting Persons sold an aggregate 18,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-255043). The aggregate 18,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 15,361,703 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,638,297 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). On April 8, 2021, the Reporting Persons sold an aggregate of 2,700,000 shares of Class A Common Stock of the Issuer pursuant to the option granted to the underwriters, which was exercised in full prior to closing. F2 · shares: (Continued from footnote 1) The aggregate 2,700,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 2,304,256 shares of Class A Common Stock sold by MLSH 1 and (b) 395,744 shares of Class A Common Stock sold by MLSH 2. F3 · balance_after: Reflects Class A Common Stock held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. F4 · balance_after: (Continued From Footnote 3) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects Class A Common Stock held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. F4 · ownership.nature: (Continued From Footnote 3) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. Read SEC document |
| November 25, 2020 Filed Nov 30, 2020 16:34 UTC |
HULL CARLDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 35,000 | $26.94 | $942,900.00 |
DisclosureSEC source: 0000899243-20-032306 · doc4.xml · nonDerivative · entry 1 HULL CARL · CIK 0001205465 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Through Glossatori, LLC Disclosed balance after: 35,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.81 to $27.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 00:52 UTC |
LUCIER GREGORY TDirector
|
PurchaseClass A Common Stock | 15,000 | $27.00 | $405,000.00 |
DisclosureSEC source: 0000899243-20-032217 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,852 Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 19:54 UTC |
Hance Robert BDirector
|
PurchaseClass A Common Stock | 10,000 | $27.00 | $270,000.00 |
DisclosureSEC source: 0000899243-20-032220 · doc4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,852 Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 00:52 UTC |
Hopfield JessicaDirector
|
PurchaseClass A Common Stock | 50,000 | $27.00 | $1,350,000.00 |
DisclosureSEC source: 0000899243-20-032216 · doc4.xml · nonDerivative · entry 1 Hopfield Jessica · CIK 0001648715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,852 Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 00:58 UTC |
GRAY SUSANNAHDirector
|
PurchaseClass A Common Stock | 20,000 | $27.00 | $540,000.00 |
DisclosureSEC source: 0000899243-20-032223 · doc4.xml · nonDerivative · entry 1 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,852 Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 00:54 UTC |
SELLERS LISASee Remarks
|
PurchaseClass A Common Stock | 18,888 | $27.00 | $509,976.00 |
DisclosureSEC source: 0000899243-20-032221 · doc4.xml · nonDerivative · entry 1 SELLERS LISA · CIK 0001829669 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,888 Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 00:53 UTC |
PRAHALAD MURALIDirector
|
PurchaseClass A Common Stock | 18,000 | $27.00 | $486,000.00 |
DisclosureSEC source: 0000899243-20-032218 · doc4.xml · nonDerivative · entry 1 PRAHALAD MURALI · CIK 0001829991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,852 Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 00:52 UTC |
ORESHACK KURTGeneral Counsel
|
PurchaseClass A Common Stock | 7,500 | $27.00 | $202,500.00 |
DisclosureSEC source: 0000899243-20-032215 · doc4.xml · nonDerivative · entry 1 ORESHACK KURT · CIK 0001832579 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 16:43 UTC |
GTCR INVESTMENT XI LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS 2, LLCDirector · 10% owner
GTCR FUND XI/B LPDirector · 10% owner
GTCR FUND XI/C LPDirector · 10% owner
GTCR CO-INVEST XI LPDirector · 10% owner
GTCR PARTNERS XI/A&C LPDirector · 10% owner
GTCR PARTNERS XI/B LPDirector · 10% owner
|
Disposition to issuerCommon Units · Derivative | 55,823,011 | $25.52 | $1,424,324,125.67 |
DisclosureSEC source: 0000899243-20-032274 · doc4.xml · derivative · entry 3 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 160,974,129 Underlying: Class A Common Stock · 160,974,129 shares Expires not disclosed F7 · derivative.exercise_price: Reflects Common Units owned directly by MLSH 1. Each Common Unit is exchangeable for one Class A Share pursuant to the Exchange Agreement. F1 · kind: On November 24, 2020, the Issuer used a portion of the net proceeds from the closing of its initial public offering ("IPO") of Class A common stock, par value $0.01 per share (the "Class A Shares"), to repurchase 1,319,148 Class A Shares held by Maravai Life Sciences Holdings 2, LLC ("MLSH 2") and to purchase 55,823,011 common units (the "Common Units") of Maravai Topco Holdings, LLC ("Topco LLC") from Maravai Life Sciences Holdings , LLC ("MLSH 1"), who were the Issuer's pre-IPO equityholders, at a price of $25.5150 per Class A Share or Common Unit. F1 · shares: On November 24, 2020, the Issuer used a portion of the net proceeds from the closing of its initial public offering ("IPO") of Class A common stock, par value $0.01 per share (the "Class A Shares"), to repurchase 1,319,148 Class A Shares held by Maravai Life Sciences Holdings 2, LLC ("MLSH 2") and to purchase 55,823,011 common units (the "Common Units") of Maravai Topco Holdings, LLC ("Topco LLC") from Maravai Life Sciences Holdings , LLC ("MLSH 1"), who were the Issuer's pre-IPO equityholders, at a price of $25.5150 per Class A Share or Common Unit. F6 · derivative.exercise_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Topco LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one Class B Share for every Common Unit) are exchangeable for one Class A Share. Common Units do not expire. F6 · derivative.expiration_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Topco LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one Class B Share for every Common Unit) are exchangeable for one Class A Share. Common Units do not expire. F7 · ownership.nature: Reflects Common Units owned directly by MLSH 1. Each Common Unit is exchangeable for one Class A Share pursuant to the Exchange Agreement. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 16:43 UTC |
GTCR INVESTMENT XI LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS 2, LLCDirector · 10% owner
GTCR FUND XI/B LPDirector · 10% owner
GTCR FUND XI/C LPDirector · 10% owner
GTCR CO-INVEST XI LPDirector · 10% owner
GTCR PARTNERS XI/A&C LPDirector · 10% owner
GTCR PARTNERS XI/B LPDirector · 10% owner
|
OtherClass B Common Stock | 7,680,852 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-032274 · doc4.xml · nonDerivative · entry 2 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 160,974,129 F4 · kind: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Shares") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F4 · shares: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Shares") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F4 · price: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Shares") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F5 · balance_after: Reflects Class B Shares held directly by Maravai Life Sciences Holdings, LLC ("MLSH 1"). MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Shares. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B shares held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B shares held of record by MLSH 1 except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects Class B Shares held directly by Maravai Life Sciences Holdings, LLC ("MLSH 1"). MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Shares. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B shares held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B shares held of record by MLSH 1 except to the extent of his pecuniary interest therein. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 16:43 UTC |
GTCR INVESTMENT XI LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner
MARAVAI LIFE SCIENCES HOLDINGS 2, LLCDirector · 10% owner
GTCR FUND XI/B LPDirector · 10% owner
GTCR FUND XI/C LPDirector · 10% owner
GTCR CO-INVEST XI LPDirector · 10% owner
GTCR PARTNERS XI/A&C LPDirector · 10% owner
GTCR PARTNERS XI/B LPDirector · 10% owner
|
Disposition to issuerClass A Common Stock | 1,319,148 | $25.52 | $33,658,061.22 |
DisclosureSEC source: 0000899243-20-032274 · doc4.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 27,646,515 F1 · kind: On November 24, 2020, the Issuer used a portion of the net proceeds from the closing of its initial public offering ("IPO") of Class A common stock, par value $0.01 per share (the "Class A Shares"), to repurchase 1,319,148 Class A Shares held by Maravai Life Sciences Holdings 2, LLC ("MLSH 2") and to purchase 55,823,011 common units (the "Common Units") of Maravai Topco Holdings, LLC ("Topco LLC") from Maravai Life Sciences Holdings , LLC ("MLSH 1"), who were the Issuer's pre-IPO equityholders, at a price of $25.5150 per Class A Share or Common Unit. F1 · shares: On November 24, 2020, the Issuer used a portion of the net proceeds from the closing of its initial public offering ("IPO") of Class A common stock, par value $0.01 per share (the "Class A Shares"), to repurchase 1,319,148 Class A Shares held by Maravai Life Sciences Holdings 2, LLC ("MLSH 2") and to purchase 55,823,011 common units (the "Common Units") of Maravai Topco Holdings, LLC ("Topco LLC") from Maravai Life Sciences Holdings , LLC ("MLSH 1"), who were the Issuer's pre-IPO equityholders, at a price of $25.5150 per Class A Share or Common Unit. F2 · balance_after: Reflects Class A Shares held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Shares. F3 · balance_after: (Continued From Footnote 2) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Shares held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Shares held of record by MLSH 2 except to the extent of his pecuniary interest therein. F2 · ownership.nature: Reflects Class A Shares held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Shares. F3 · ownership.nature: (Continued From Footnote 2) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Shares held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Shares held of record by MLSH 2 except to the extent of his pecuniary interest therein. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:29 UTC |
Ashkenazi AnatDirector
|
GrantClass A Common Stock | 11,852 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031938 · doc4.xml · nonDerivative · entry 1 Ashkenazi Anat · CIK 0001761679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,852 Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:37 UTC |
Dolan ChristineSee Remarks
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $27.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031956 · doc4.xml · derivative · entry 1 Dolan Christine · CIK 0001684273 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Class A Common Stock · 60,000 shares Expires 2030-11-19 F1 · derivative.exercise_date: Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan in connection with the pricing of the Issuer's initial public offering. These options will vest 25% on November 19, 2021 and in equal monthly installments thereafter over the next three years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 17:32 UTC |
Herde KevinChief Financial Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $27.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031947 · doc4.xml · derivative · entry 1 Herde Kevin · CIK 0001671595 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Class A Common Stock · 60,000 shares Expires 2030-11-19 F1 · derivative.exercise_date: Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan in connection with the pricing of the Issuer's initial public offering. These options will vest 25% on November 19, 2021 and in equal monthly installments thereafter over the next three years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 17:29 UTC |
Tardif EricPresident
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $27.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031939 · doc4.xml · derivative · entry 1 Tardif Eric · CIK 0001453864 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Class A Common Stock · 60,000 shares Expires 2030-11-19 F1 · derivative.exercise_date: Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan in connection with the pricing of the Issuer's initial public offering. These options will vest 25% on November 19, 2021 and in equal monthly installments thereafter over the next three years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 17:33 UTC |
HULL CARLDirector · Chief Executive Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $27.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031948 · doc4.xml · derivative · entry 1 HULL CARL · CIK 0001205465 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Class A Common Stock · 60,000 shares Expires 2030-11-19 F1 · derivative.exercise_date: Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan in connection with the pricing of the Issuer's initial public offering. These options will vest 25% on November 19, 2021 and in equal monthly installments thereafter over the next three years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:36 UTC |
LUCIER GREGORY TDirector
|
GrantClass A Common Stock | 11,852 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031954 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,852 Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 17:27 UTC |
Hance Robert BDirector
|
GrantClass A Common Stock | 11,852 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031934 · doc4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,852 Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:32 UTC |
Hopfield JessicaDirector
|
GrantClass A Common Stock | 11,852 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031946 · doc4.xml · nonDerivative · entry 1 Hopfield Jessica · CIK 0001648715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,852 Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:37 UTC |
NEEL BRIANSee Remarks
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $27.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031955 · doc4.xml · derivative · entry 1 NEEL BRIAN · CIK 0001829754 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Class A Common Stock · 60,000 shares Expires 2030-11-19 F1 · derivative.exercise_date: Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan in connection with the pricing of the Issuer's initial public offering. These options will vest 25% on November 19, 2021 and in equal monthly installments thereafter over the next three years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:35 UTC |
ORESHACK KURTGeneral Counsel
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $27.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031952 · doc4.xml · derivative · entry 1 ORESHACK KURT · CIK 0001832579 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2030-11-19 F1 · derivative.exercise_date: Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan in connection with the pricing of the Issuer's initial public offering. These options will vest 25% on November 19, 2021 and in equal monthly installments thereafter over the next three years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:30 UTC |
SELLERS LISASee Remarks
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $27.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031942 · doc4.xml · derivative · entry 1 SELLERS LISA · CIK 0001829669 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Class A Common Stock · 60,000 shares Expires 2030-11-19 F1 · derivative.exercise_date: Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan in connection with the pricing of the Issuer's initial public offering. These options will vest 25% on November 19, 2021 and in equal monthly installments thereafter over the next three years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:29 UTC |
PRAHALAD MURALIDirector
|
GrantClass A Common Stock | 11,852 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031940 · doc4.xml · nonDerivative · entry 1 PRAHALAD MURALI · CIK 0001829991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,852 Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 22:27 UTC |
GRAY SUSANNAHDirector
|
GrantClass A Common Stock | 11,852 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031935 · doc4.xml · nonDerivative · entry 1 GRAY SUSANNAH · CIK 0001833453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,852 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.